Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
FDHT-PET scan
DIAGNOSTIC_TEST
2 trials
Sponsors
University Medical Center Groningen
, Medical University of Vienna
Conditions
Metastatic Breast Cancer
Prostate Cancer
Phase 2
AR and ER Imaging in Metastatic Breast Cancer
Completed
NCT01988324
University Medical Center Groningen
Metastatic Breast Cancer
Start: 2014-08-31
End: 2015-09-30
Updated: 2024-05-06
Unknown Phase
Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer
Withdrawn
NCT05245435
Medical University of Vienna
Prostate Cancer
Start: 2022-04-30
End: 2024-09-30
Updated: 2023-03-20
Related Papers
Visual and quantitative evaluation of [<sup>18</sup>F]FES and [<sup>18</sup>F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study.
2020-04-19
13 citations
Androgen receptor and estrogen receptor imaging in patients with metastatic breast cancer.
Journal of Clinical Oncology
2016-05-20
3 citations